|Last Price||Today's Change||52-Week Range||Trading Volume|
|49.55||0.23 (+0.46%)||41.11 - 57.49||5.5 million (Above Avg)|
Market data as of 1:43PM 07/24/14. Quotes are delayed by at least 15 min.
Bristol-Myers Squibb Reports Second Quarter 2014 Financial Results
07/24/2014 7:30 AM ET
Bristol-Myers Squibb and Pfizer Announce Enrollment of First Patient in Phase IV EMANATE Trial to Assess Effectiveness and Safety of Eliquis® (apixaban) in Patients with NVAF Undergoing Cardioversion
07/17/2014 8:06 AM ET